Trial record 1 of 1 for:    mrx34
Previous Study | Return to List | Next Study

A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposome Injectable Suspension

This study is currently recruiting participants.
Verified October 2013 by Mirna Therapeutics, Inc.
Sponsor:
Collaborator:
Cancer Prevention Research Institute of Texas (CPRiT)
Information provided by (Responsible Party):
Mirna Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT01829971
First received: April 8, 2013
Last updated: October 28, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)